tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Insmed assumed with an Overweight at Cantor Fitzgerald
PremiumThe FlyInsmed assumed with an Overweight at Cantor Fitzgerald
3d ago
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment
Premium
Company Announcements
Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment
3d ago
Positive Outlook for Insmed: Promising Product Pipeline and Favorable Market Position Justify Buy Rating
PremiumRatingsPositive Outlook for Insmed: Promising Product Pipeline and Favorable Market Position Justify Buy Rating
8d ago
Optimistic Buy Rating for Insmed’s Brinsupri Amid Strong Market Potential and Expansion Opportunities
Premium
Ratings
Optimistic Buy Rating for Insmed’s Brinsupri Amid Strong Market Potential and Expansion Opportunities
11d ago
Insmed says CHMP recommends EU approval of BRINSUPRI
Premium
The Fly
Insmed says CHMP recommends EU approval of BRINSUPRI
14d ago
Insmed’s TPIP Shows Promising Phase 2 Results, Boosting Buy Rating and Future Prospects
PremiumRatingsInsmed’s TPIP Shows Promising Phase 2 Results, Boosting Buy Rating and Future Prospects
29d ago
Insmed price target raised to $180 from $110 at Evercore ISI
Premium
The Fly
Insmed price target raised to $180 from $110 at Evercore ISI
30d ago
Measured Optimism and Caution: Maxwell Skor’s Hold Rating on Insmed Amid Promising Brinsupri Launch
Premium
Ratings
Measured Optimism and Caution: Maxwell Skor’s Hold Rating on Insmed Amid Promising Brinsupri Launch
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100